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Health status and quality of life in patients with diabetes in Switzerland 
Abstract 
Aims: We aimed to assess the health status and quality of life (QoL) of patients with diabetes and 
explore the associated factors in a French-speaking region of Switzerland. 
Methods: This cross-sectional study analyzed self-reported data from 585 patients with diabetes. We 
ran univariate and multivariate regressions analyses on health status (Physical and Mental Component 
Summary scores (PCS, MCS) of the SF-12) and diabetes-specific QoL (ADDQoL score). 
Results: Mean PCS was 43.1 ±10.4 and mean MCS was 46.7 ±11.1. The overall ADDQoL score was -
1.6 ±1.6; the life domains of the ADDQoL with the lowest scores were freedom to eat, sex life and 
freedom to drink. Being older was independently and significantly associated with higher mental health 
and QoL, while lower income was associated with lower physical health, mental health, and QoL. 
Having diabetes for over 10 years was associated with lower QoL, while insulin treatment and 
complications were correlated with lower physical health and QoL. 
Conclusions: This study provides key information on the health status and QoL of patients with diabetes 
in Switzerland and their associated factors, which can help healthcare providers to identify patients at 
higher risk of lower health and QoL. 
Keywords : diabetes, health status, quality of life, SF-12, ADDQoL, Switzerland 
Abbreviations1 
  
                                                     
1 Abbreviations: QoL, quality of life; PCS, physical component summary; MCS, mental component summary; SF-
12, 12-Item short form health survey; ADDQoL, audit of diabetes-dependent quality of life; CoDiab-VD, Cohorte 
des patients diabétiques vaudois; SWIDINEP, Swiss diabetes nephropathy; BMI, body mass index; OAA, oral 
antidiabetic agents; HbA1c, haemoglobin A1c 
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1 Introduction 
Diabetes is on the rise and one of the major global health burdens worldwide, with about 425 million 
people suffering from diabetes in 2017, representing an average prevalence of 8.8% among adults [1]. 
The age-adjusted prevalence of diabetes was 5.6% in Switzerland in 2017 [1], and it was estimated to 
be 6.6% in the canton of Vaud, a Swiss state of about 720’000 residents [2]. While the overall goal of 
diabetes care is to prolong life and prevent acute and chronic complications, an important goal is also 
to preserve patients’ perceived health and quality of life (QoL). Quality of life goes beyond disease and 
health and is defined as an “individual’s perception of their position in life in the context of the culture 
and value systems in which they live and in relation to their goals, expectations, standards and concerns 
(…)” [3]. Numerous instruments, generic and disease-specific, have been developed to measure both 
perceived health status and QoL, through questionnaires that collect data directly from patients, in a 
context of increasing attention towards the consideration of patient-reported outcomes [4, 5]. It is in fact 
important for healthcare systems to assess the health status and QoL of patients in addition to their 
disease levels to evaluate how the system is performing, also according to the patients; to our 
knowledge, this has yet to be done in Switzerland on a large scale.  
In addition to the assessment of health status and QoL, information about their associated factors could 
help providers to identify patients at higher risk of poor health and QoL. In patients with diabetes, 
previous studies and reviews on factors correlated with health status and QoL have shown mixed and 
conflicting results on the association between clinical and socio-demographic characteristics and level 
of health and QoL. While the presence and number of complications is usually associated with lower 
levels of health status and QoL [6, 7], glycemic control is not always correlated with better QoL scores, 
especially when QoL is measured with a generic measure [8]. The effect of duration of disease, 
treatment regimen, and type of diabetes is uncertain and variable [6]. Finally, among the socio-
demographic characteristics, older age has been associated with reduced physical functioning but 
improved mental health, while being a man and of higher socio-economic status has been associated 
with higher scores of QoL [6, 9].  
In this cross-sectional study, the primary objective was thus to assess health status and QoL in patients 
with diabetes in a French-speaking region of Switzerland, using a generic health status measure and a 
diabetes-specific QoL measure. The secondary objective was to explore and compare the 
characteristics independently associated with health status and QoL.  
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2 Methods 
2.1 Study design and study population 
This cross-sectional analysis is based on available data for non-institutionalized adults with diabetes in 
the Canton of Vaud, a French-speaking canton of Switzerland of about 720’000 residents. The data are 
derived from the baseline data of two cohorts: the “Cohorte des patients diabétiques vaudois” (CoDiab-
VD) cohort [10] and the “Swiss Diabetes Nephropathy” (SWIDINEP) cohort. The CoDiab-VD cohort 
consists of 514 respondents with diabetes (49.2% response rate), recruited in 2011-2012 in community-
based pharmacies, while the SWIDINEP cohort consists of 71 respondents with a diabetes kidney 
disease diagnosis (54.2% response rate), recruited in 2013 in ambulatory nephrology and diabetes 
clinics. Individuals under dialysis, with a kidney transplant, with another associated kidney diagnosis, 
with obvious cognitive impairment, not speaking or understanding French well enough, as well as 
women with gestational diabetes, were excluded.  
2.2 Health status and QoL (dependent variables) 
Generic health status was assessed with the 12-Item Short Form Health Survey (SF-12), which provides 
two norm-based scores measuring functional health and well-being from the patient’s point of view: the 
Physical Component Summary (PCS) and the Mental Component Summary (MCS) scores [11]. Scores 
range from 0 (lowest level of health) to 100 (highest level of health) and were initially calibrated so that 
50 is the average score or norm for the US general population, with a standard deviations equalized to 
10 [12]. In Switzerland, the PCS and MCS scores were respectively 49.8 (SD 8.6) and 46.7 (SD 10.1) 
in a sample of Swiss residents in the canton of Vaud from a study performed to establish local population 
norms for health status questionnaires [13]. 
Diabetes-specific QoL was assessed with the third version of the Audit of Diabetes-Dependent Quality 
of Life (ADDQoL) [14, 15], a validated and widely recommended instrument with good psychometric 
properties [16-18]. The instrument contains two overall items: generic QoL, on a 7-point scale from 
extremely poor to excellent, and overall impact of diabetes on QoL, on a 4-point scale from maximum 
negative impact of diabetes to maximum positive impact of diabetes. Impact of diabetes is then 
measured on 19 life domains: respondents rate the impact of diabetes on the life domain on a 5-point 
scale, from −3 (maximum negative impact of diabetes) to 1 (positive impact of diabetes), and the 
importance of the domain for their quality of life on a 4-point scale, from 0 (not all important) to 3 (very 
important). The two ratings are multiplied to generate the weighted impact score for each domain, which 
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can be averaged to form a single average-weighted impact score (i.e. overall ADDQoL score throughout 
the text), ranging from -9 (maximum negative impact of diabetes) to +3 (maximum positive impact of 
diabetes). Five of the items that may not be relevant for some people have a preliminary question that 
determines the relevance of the dimension, and are ignored in the overall score if not applicable. 
We collected both measures from participants through a self-administered paper questionnaire. 
2.3 Independent variables 
In the analyses, we included the following independent variables previously reported as potential 
determinants of health status and/or QoL: i) socio-demographic characteristics: age, gender, living 
situation (living with someone vs alone), education (primary, secondary, tertiary), employment 
status,(full-time, part-time, retired/annuitant, unemployed/disabled/at home), and household income; ii) 
diabetes-specific characteristics: type, duration, type of treatment (oral hypoglycemic agents, insulin, 
combination, none/unknown), presence of complications (neuropathy, retinopathy, nephropathy, 
cardiovascular disease, cerebrovascular disease, amputation), and HbA1c level; and iii) risk factors and 
other clinical characteristics: smoking status (current smoker, former smoker, never), body mass index 
(BMI), systolic, diastolic, and pulse blood pressure, and cholesterol values. These variables were 
collected both with self-administered questionnaires (socio/demographic characteristics) and treating 
physicians (clinical characteristics). 
2.4 Data analysis 
For the primary objective, we ran univariate analyses on the socio-demographic and clinical 
characteristics, as well as on the health status measures (MCS and PCS scores) and the diabetes-
specific QoL measures (generic QoL, overall impact of diabetes on QoL, overall ADDQoL score, and 
individual domain scores). For the secondary objective, we performed multivariate linear regressions 
with backward manual selection to identify independent variables associated with the MCS, PCS, and 
overall ADDQoL scores, respectively. We included in the initial model all variables associated with the 
dependent variable (P-value≤0.15) in the univariate analyses. We eliminated variables based on P-
value, explained variance (R2), and number of missing data. We also ran similar multivariate linear 
regression models to identify the variables independently associated with the three most impacted 
ADDQoL domains. We performed regression diagnostics on all final models, removing unusual and 
influential observations in sensitivity analyses based on the Cook’s D test. We also performed sensitivity 
analyses, running the analyses in patients with type 2 diabetes only (n=506) and in patients from the 
CoDiab-VD cohort only (n=514). 
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3 Results 
3.1 Participant characteristics, health status and QoL 
Demographic and clinical characteristics are presented in Table 1. Mean PCS and MCS scores were 
43.1 ±10.4 and 46.7 ±11.1, respectively. While 68% of respondents rated their general QoL as good, 
very good or excellent, 68% also reported that their QoL would be better if they did not have diabetes. 
The weighted impact scores were negative for all 19 domains of the ADDQoL, with the lowest negative 
scores observed for ‘freedom to eat’ (mean = -2.7 ±2.9), ‘sex life’ (mean = -2.6 ±2.9) and ‘freedom to 
drink’ (mean -2.0 ±2.5) and the least negative scores seen for ‘reaction of others’ (-0.5 ±1.5), ‘financial 
situation’ (-1.0 ±2.2) and self-confidence (-1.3 ±2.4) (see Figure 1). In other words, 71%, 60% and 57% 
of respondents reported that diabetes had a negative impact on their freedom to eat, drink and sex life, 
respectively, while only 16%, 28% and 32% of respondents reported that diabetes had a negative 
impact on reaction of others, their financial situation and their self-confidence. The mean overall 
ADDQoL score was -1.6 ±1.6 and 91% of respondents had a negative overall ADDQoL score. 
3.2 Characteristics associated with health status and QoL 
The association between each of the measures (PCS, MCS, and overall ADDQoL score) and the socio-
demographic, diabetes-specific, and risk factors characteristics are presented in Table 2. Diabetes-
related characteristics explained more variance than sociodemographic characteristics for the level of 
physical functioning and QoL, while sociodemographic characteristics explained more variance for the 
level of mental well-being.  
The PCS regression model included eight variables explaining 28.7% of the variance, while the MCS 
and the overall ADDQoL regression models included seven variables, explaining 6.6% and 16.6% of 
the variance respectively. In the multivariate models, lower income was independently associated with 
lower PCS, MCS and QoL, while being older was independently associated with better MCS and QoL. 
Whereas type 2 diabetes was associated with lower PCS and better MCS, it was not statistically 
associated with QoL. A 10-year or more diagnosis of diabetes was correlated with worse QoL only. 
Insulin treatment, alone or in combination with oral antidiabetic agents, were associated with lower PCS 
and QoL. The presence of neuropathy was correlated with lower PCS and QoL, while retinopathy and 
cardiovascular disease were correlated with lower QOL, and cerebrovascular disease was correlated 
with lower PCS. Finally, employment status and BMI were independently associated with PCS only.  
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The characteristics associated with the three lowest ADDQoL life domain scores are presented in Table 
3. The models for ‘freedom to eat’ and ‘freedom to drink’ were similar and included three common 
variables out of four, explaining 4.9% and 4.3% of the variance, respectively: being older was 
associated with less negative scores for freedom to eat and drink, while being treated with both insulin 
and oral agents and reporting cardiovascular complications were associated with greater negative 
scores. The regression model for ‘sex life’ included six variables explaining 17.1% of the variance: being 
a man, having a diagnosis of diabetes for over 10 years, receiving combination therapy, and reporting 
neuropathy and cerebrovascular disease were associated with greater negative impact of diabetes on 
sex life, while having higher level of education was associated with less impact.  
Removing influential observations increased the adjusted R2 of all models, while regression coefficients 
remained comparable. In sensitivity analyses, restricting the analyses to the CoDiab-VD cohort slightly 
changed the PCS model, with age>75 and cardiovascular disease becoming characteristics 
significantly associated with PCS scores. Restricting the analyses to patients with type 2 diabetes also 
slightly changed the ADDQoL model, with higher education becoming a characteristic significantly 
associated with better QoL. Finally, we also ran the multivariate analyses with HbA1c as an independent 
variable in patients with HbA1c data (n=414). While higher levels of HbA1c was significantly associated 
lower PCS, HbA1c was not significantly associated with QoL or MCS. 
4 Discussion 
Patients with diabetes in the French-speaking Swiss canton of Vaud reported lower physical functioning 
but similar mental well-being scores compared to the population-based scores established in the region 
in a previous study [13]. According to the respondents, diabetes had an overall negative impact on their 
QoL, as measured with the diabetes-specific QoL measure (overall ADDQoL score). More specifically, 
the respondents reported that diabetes had the most negative impacts on freedom to eat as wished, 
sex life, and freedom to drink as wished. The factors independently associated with health status and 
QoL in our Swiss population with diabetes were multiple and related to socio-demographic and 
diabetes-specific characteristics, these latter characteristics explaining more variance in physical 
functioning (PCS) and QoL (ADDQoL) than socio-demographic characteristics. Three common factors 
associated with lower PCS and QoL emerged from our regression analyses: lower income, receiving 
insulin (alone or in combination with oral antidiabetic agents), and the presence of neuropathy.  
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Dietary freedom was reported as the most impacted life domain in our study, as well as in many studies 
using the ADDQoL in a range of countries in Europe [19-25], Asia [26-28], and Australia [29]. Diabetes 
requires dietary restrictions as well as constant monitoring of food intake, exercise and glucose levels 
to decrease the risk of developing complications and thus increase the likelihood of better health and 
QoL in the future. Self-management interventions need to balance the immediate negative impacts of 
dietary restrictions on patients with the future positive impacts of self-management in preventing the 
deterioration of health. In our population, younger individuals, treated with insulin and oral antidiabetic 
agents, and suffering from cardiovascular complications tended to report worse scores regarding the 
impact of diabetes on their freedom to eat and drink, suggesting that treating physicians should 
particularly pay attention to patients with these characteristics when implementing self-management 
plans and discussing dietary restrictions.  
The low QoL score for sex life reported in our population has also been reported in other studies using 
the ADDQoL [23, 29]. Lower sex life scores were correlated with by being a man, diagnosed for more 
than 10 years, and suffering from cerebrovascular complications and neuropathy. This is not surprising 
as the pathophysiology for erectile dysfunction in men with diabetes is well known and includes vascular 
and nerve system dysfunctions to diabetes [30]. Diabetes has also been associated with lower scores 
for sexual desire, activity, arousal and satisfaction in men [30]. This is an important issue that should 
be tackled by treating physicians as it may be corrected by treatments, such as phosphodiesterase type 
5 inhibitors and prostaglandin-E1 injections, and thus improved patients’ sex life. 
Regarding the global diabetes-related QoL as expressed by the overall ADDQoL score, the mean score 
in our population was among the least negative in the published literature using the same instrument  
(e.g. [19, 29, 31]) with most studies reporting worse scores (e.g. [8, 32, 33]). These differences are 
likely due to multiple factors, among which we can cite the healthcare system and context: Switzerland 
is a privileged country with universal health insurance, relatively easy access to care and good 
reimbursement policies, as further evidenced by the fact that the impact of diabetes on patient’s financial 
situation was the second least impacted domain in our population.  
The socio-demographic and diabetes-specific characteristics collected in our survey did not explain 
much of the variance in mental well-being. Other factors that we did not measure in our study, such as 
personality trait and coping style, may be stronger determinants of mental health than diabetes-related 
clinical characteristics.  
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Regarding characteristics associated with physical functioning (PCS) and QoL, the finding that the 
lowest income was associated with both lower PCS and QoL is consistent with other studies [29, 34], 
while our finding that gender was not a significant factor is in contrast to previous studies [9]. Older 
individuals were more likely to report higher QoL scores than younger individuals, although older 
individuals tended to report lower PCS. It appears that although physical health decreases with age, 
older patients reported less negative impact of diabetes on their quality of life. It may be explained by 
expectations that decline with age: older respondents expecting lower QoL rate their QoL higher than 
younger respondents expecting higher QoL [29]. While patients with type 2 diabetes reported lower 
PCS than patients with type 1 diabetes, they tended to report less negative impact of diabetes on their 
QoL, although the association was not statistically significant in multivariate analyses. Respondents 
diagnosed for more than ten years reported lower QoL scores than patients diagnosed for a shorter 
period. In the literature, the association between duration of diabetes and QoL is mixed, with studies 
finding that increased duration of diabetes was associated with decreased QoL [9, 28, 35], while others 
found no association [36]. As previously shown [29], the presence of complications was associated with 
lower PCS and QoL, but neuropathy, retinopathy and cardiovascular disease were the three 
complications that remained in the final multivariate model for QoL, suggesting that they are the 
strongest factors associated with poor QoL. These characteristics can inform treating physicians and 
intervention planners about patients who are more at risk for deterioration of quality of life and therefore 
require more attention and careful self-management planning. 
The strength of our study reside in the use of validated measures of both health status and QoL 
measures capturing a more complete picture of our population and the use of both a generic and 
disease-specific instrument, as suggest by Rubin and Peyrot [6] who advocate the use of both generic 
and disease-specific instruments. This is also the first study to our knowledge to assess health status 
and QoL among patients with diabetes in a large French-speaking region of Switzerland. Interpretation 
of our findings are however limited by several factors. First, most data were self-reported, possibly 
resulting in under- or over-reporting of medical conditions, complications and comorbidities, included 
as covariates in our analyses. For instance, the rate of self-reported nephropathy (15.8%) was lower 
than the creatinine-based rate reported in another Swiss study (22.4%) among patients with type 2 
diabetes seen in primary care settings [37]. The effect of such under- or over-reporting remains 
unknown, however. Second, we did not adjust for HbA1c values in our multivariate models because 
data were missing for many participants. The additional analyses run to explore the role of HbA1c in 
the subset of patients with data showed that higher HbA1c was a factor associated with lower physical 
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health, but not with QoL, as previously shown in other studies [8, 38, 39]. Third, the explained variances 
(adjusted R2) we achieved in our models were relatively small, although comparable to other studies 
(e.g. [8, 38]). The addition of other explanatory factors, such as attitudinal factors (e.g. personality trait 
and coping style) and other psychosocial factors (e.g. depression and stress), which have been 
previously associated with QoL [40-42], would probably improve the explained variance but they were 
not measured in our population. In sensitivity analyses including patients from the CoDiab-VD cohort 
only, for whom a measure of depression was available [43], depression was significantly associated 
with lower QoL and increased the total explained variance to 25%. Fourth, the cross-sectional nature 
of our study prevents us from drawing conclusions on causality between associated factors and health 
status and QoL. Lastly, it is difficult to assess whether we can generalize these results to other countries 
or even Swiss cantons speaking a different language. Cross-national and cross-cultural generalizations 
are strongly limited by the fact that cultural norms and language likely influence the way individuals rate 
their QoL. 
In conclusion, this study provides key information on the perceived health status and quality of life of 
patients with diabetes in Switzerland. While the health status measures tell us that patients with 
diabetes perceive their physical functioning as lower compared to the Swiss population-based norm, 
the QoL measure tells us which life domains are particularly affected by diabetes, namely the freedom 
to eat and drink as wished, and sex life. The factors independently associated with health status and 
QoL can help healthcare providers to identify patients at higher risk of lower physical functioning, mental 
well-being and QoL.  
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 Table 1: Participant characteristics  
 N % or mean (SD) 
Socio-demographic characteristics 
Age 
>65 years old 
585 64.3 (11.4) 
55.1% 
Women 585 38.3% 
Living with someone (vs alone) 580 72.4% 
Swiss nationality (vs non-Swiss) 580 86.6% 
Education 
Primary  
Secondary  
Tertiary 
566 
 
 
19.1% 
55.5% 
25.4% 
Employment status 
Full-time 
Part-time 
Retired/annuitant 
Unemployed/disabled/at-home 
565 
 
 
23.7% 
8.7% 
57.0% 
10.6% 
Household income, CHF/month 
≤3499 
3500-5499 
550-9499 
≥9500 
507 
 
 
23.3% 
29.8% 
29.2% 
17.8% 
Diabetes-specific characteristics 
Type 2 Diabetes 585 86.5% 
Diagnosis >10 years 569 49.6% 
Treatment 
Oral antidiabetic agents 
Insulin 
Combination  
None / unknown 
583 
 
 
 
(3) 
 
48.9% 
21.4% 
29.2% 
0.5% 
Complications   
Neuropathy 564 27.3% 
Retinopathy 499 18.6% 
Nephropathy 570 15.8% 
Cardiovascular disease 570 13.7% 
Cerebrovascular disease 569 4.0% 
Amputation 
≥1 complication 
563 
570 
2.8% 
45.6% 
HbA1c 
<7.0% 
414 7.3 (1.2) 
42.8% 
Risk factors and other clinical characteristics 
Smoking status 
Current smoker 
Former smoker 
Never 
575  
18.3% 
45.4% 
36.4% 
BMI 
Obese (BMI≥30) 
547 30.2 (5.7) 
47.9% 
Blood pressure, mmHg 
Systolic 
Diastolic 
Pulse 
 
458 
445 
445 
 
133.9 (15.0) 
78.0 (9.5) 
57.5 (14.6) 
Cholesterol total, mmol/l 321 4.6 (1.0) 
LDL-C, mmol/l 295 2.5 (0.9) 
HDL-C, mmol/l 314 1.3 (0.6) 
Triglycerides, mmol/l 318 1.9 (1.4) 
CHF, Swiss francs; HbA1c, haemoglobin A1c; BMI, body mass index; LDL-C, LDL-cholesterol; HDL-C, HDL cholesterol 
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Figure 1: ADDQoL average weighted impact (AWI) and individual weighted impact scores by 
domain (lower score=worse QoL, classified by decreasing order, with 95% confidence intervals) 
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Table 2 Univariate and multivariate linear regression coefficients in SF-12 PCS, SF-12 MCS and 
overall ADDQoL models 
 SF-12 PCS model SF-12 MCS model Overall ADDQoL 
model 
 Univar 
coeff 
Multivar 
coeff 
(R2)  
Univar 
coeff 
Multivar 
coeff 
(R2) 
Univar 
coeff 
Multivar 
coeff 
(R2) 
Socio-demographic 
characteristics 
 (12.2%)  (7.0%)  (6.7%) 
Age (ref: <65) 
65-74 
>=75 
 
-2.81*** 
-4.82*** 
 
0.25 
-2.83* 
 
4.25*** 
2.77** 
 
3.32** 
1.40 
 
0.45*** 
0.49** 
 
0.58*** 
0.65*** 
Men 1.06  1.10  -0.06  
Living with someone 
(ref: alone) 
2.72***  1.85*  0.02  
Swiss nationality (ref: 
non-Swiss) 
1.02  4.58*** 2.62* 0.61***  
Education (ref: primary) 
Secondary  
Tertiary 
 
2.23* 
3.72*** 
 
 
 
 
2.48* 
3.69** 
 
 
 
 
0.58*** 
0.45** 
 
 
Employment (ref: full-time) 
Part-time 
Retired/ annuitant 
Unemployed/disabled 
 
-2.81* 
-7.02*** 
-8.99*** 
 
-2.00 
-3.97*** 
-6.15*** 
 
0.09 
1.27 
-5.29*** 
 
-0.52 
-0.14 
-3.71* 
 
-0.42 
0.08 
-0.39 
 
Income (ref: ≤3499) 
3500-5499 
5500-9499 
≥9500 
 
3.89*** 
5.04*** 
7.75*** 
 
2.69** 
1.41 
2.44* 
 
3.47** 
1.67 
4.30*** 
 
3.56** 
1.33 
3.87** 
 
0.48** 
0.21 
0.47** 
 
0.41** 
0.07 
0.39* 
Diabetes-specific 
characteristics 
 (22.6%)  (4.1%)  (17.6%) 
Type 2 diabetes (ref: 
type 1) 
-6.46*** -4.73** 4.35*** 3.68** 0.75***  
Diagnosis >10 years 
(ref: <10 years) 
-1.94**  -2.03** -1.98* -0.68*** -0.39*** 
Treatment (ref: OAA) 
Insulin 
Combination 
 
-2.84** 
-3.73*** 
 
-5.42*** 
-3.70*** 
 
-2.65** 
-1.81* 
 
 
 
 
-0.99*** 
-0.93*** 
 
-0.53*** 
-0.63*** 
Complications  
Neuropathy   
Retinopathy  
Nephropathy 
Cardiovascular disease 
Cerebrovascular disease 
Amputation 
 
-7.31*** 
-3.80*** 
-3.49*** 
-3.74** 
-9.57*** 
-8.67*** 
 
-5.10*** 
 
 
 
-7.92*** 
 
 
-1.17 
-1.41 
-2.08 
0.79 
-0.57 
0.16 
 
 
 
-2.55* 
 
-0.63*** 
-0.74*** 
-0.65*** 
-0.81*** 
-0.65* 
-0.66 
 
-0.37** 
-0.37** 
 
-0.54*** 
 
 
HbA1c† -1.38***  -0.74*  -0.38***  
Risk factors  (8.0%)  (1.0%)  (0.6%) 
Smoking (ref: never) 
Former smoker 
Current smoker 
 
-1.67* 
-0.75 
 
 
 
1.96* 
-1.81 
 
 
 
 
0.16 
0.08 
 
 
BMI (ref: underw/normal) 
Overweight 
Obese 
 
-4.66*** 
-8.06*** 
 
-4.18*** 
-7.53*** 
 
0.32 
0.36 
 
 
 
0.03 
-0.21 
 
 
Adjusted R2 (full model)  28.7%  6.6%  16.6% 
*<0.10; **<0.05; ***<0.01; †HbA1c omitted in the multivariate model because of missing data; univar coeff, coefficients in univariate 
analyses; multivar coeff, coefficients of variables remaining in the multivariate model after backward elimination; BMI, body mass index; 
OAA, oral antidiabetic agents; ref, reference; underw, underweight; HbA1c, haemoglobin A1c 
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Table 3 Univariate and multivariate linear regression coefficients in the freedom to eat, freedom 
to drink, and sex life models 
 Freedom to eat Freedom to drink Sex life 
 Univar 
coeff 
Multivar 
coeff (R2) 
Univar 
coeff 
Multivar 
coeff (R2) 
Univar 
coeff 
Multivar 
coeff (R2) 
Socio-demographic 
characteristics  
 (4.9%)  (5.2%)  (8.3%) 
Age (ref: <65) 
65-74 
>=75 
 
0.79*** 
0.10** 
 
0.77*** 
0.76** 
 
0.74*** 
0.66** 
 
0.77*** 
0.71** 
 
0.43 
0.00 
 
 
Men  -0.01  -0.08  -1.55*** -1.52*** 
Living with someone (ref: 
alone) 
0.26  0.28  -0.03  
Swiss nationality (ref: 
non-Swiss) 
0.12  -0.06  0.03  
Education (ref: primary) 
Secondary  
Tertiary 
 
0.90*** 
0.59 
 
0.92*** 
0.57 
 
0.12 
-0.36 
 
 
 
 
0.87** 
0.58 
 
0.89** 
0.87** 
Employment (ref: full-time) 
Part-time 
Retired/ annuitant 
Unemployed/disabled 
 
0.01 
0.59* 
-0.30 
  
0.40 
0.46* 
-0.32 
 
 
 
 
0.21 
0.10 
-0.21 
 
Income (ref: ≤3499) 
3500-5499 
5500-9499 
≥9500 
 
0.22 
-0.002 
0.11 
  
-0.17 
-0.33 
-0.56 
 
 
 
 
0.09 
0.27 
0.20 
 
Diabetes-specific 
characteristics 
 (6.3%)  (7.3%)  (13.0%) 
Type 2 diabetes -0.14  0.20  0.29  
Diagnosis >10 years -0.29  -0.25  -1.24*** -0.78** 
Treatment (ref: OAA) 
Insulin 
Combination 
 
-0.32 
-1.05*** 
 
0.01 
-0.95*** 
 
-0.64** 
-0.76*** 
 
-0.43 
-0.59** 
 
-1.06*** 
-1.24*** 
 
-0.57 
-0.77** 
Complications  
Neuropathy   
Retinopathy  
Nephropathy 
Cardiovascular disease 
Cerebrovascular disease 
Amputation 
 
-0.32 
-0.11 
-0.11 
-0.79** 
0.45 
-0.46 
 
 
 
 
-0.66* 
 
-0.55** 
0.06 
-0.06 
-0.74** 
-0.59 
0.83 
 
-0.53** 
 
 
-0.73** 
 
-1.48*** 
-1.09*** 
-1.47*** 
-1.26*** 
-3.29*** 
-0.97 
 
-1.12*** 
 
 
 
-2.76*** 
HbA1c† -0.44***  -0.38***  -0.28**  
Risk factors  (1.1%)  (0.1%)  (1.5%) 
Smoking (ref: never) 
Former smoker 
Current smoker 
 
0.19 
0.50 
  
0.16 
0.13 
 
 
 
 
-0.53 
-0.39 
 
BMI (ref: underw/normal) 
Overweight 
Obese 
 
-0.06 
-0.60 
  
-0.14 
-0.22 
 
 
 
 
-0.33 
0.37 
 
Adjusted R2  4.9%  4.3%  17.1% 
*<0.10; **<0.05; ***<0.01; †HbA1c omitted in the multivariate model because of missing data; univar coeff, coefficients in univariate 
analyses; multivar coeff, coefficients of variables remaining in the multivariate model after backward elimination; BMI, body mass index; 
OAA, oral antidiabetic agents; ref, reference; underw, underweight; HbA1c, haemoglobin A1c 
